Plasma acylation stimulating protein (ASP) as a predictor of impaired cellular biological response to ASP in patients with hyperapoB

European Journal of Clinical Investigation

Volumn 28, Issue 9, 1998, Pages 730-739

  Zhang, X J ^a   Cianflone, K ^a   Genest, J ^b   Sniderman, A D ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Complement C3adesarg; Familial combined hyperlipidaemia; Glucose transport; Hyperapobetalipoproteinaemia; Receptor; Triglyceride synthesis

Indexed keywords

ACYLATION STIMULATING PROTEIN; APOLIPOPROTEIN B; BASIC PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING AFFINITY; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SKIN FIBROBLAST;

ADULT; AGED; APOLIPOPROTEINS B; BINDING, COMPETITIVE; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD PROTEINS; CELL LINE; COMPLEMENT C3A; FEMALE; FIBROBLASTS; GLUCOSE; HUMANS; HYPERLIPOPROTEINEMIAS; INSULIN; MALE; MIDDLE AGED; TETRADECANOYLPHORBOL ACETATE; TRIGLYCERIDES;

EID: 0031712435     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00359.x     Document Type: Article

References (37)

1. Baldo A, Sniderman AD, St-Luce S, et al. The adipsin-acylation stimulating protein system and regulation of intra-cellular triglyceride synthesis. J Clin Invest 1993; 92: 1543-7.
2. Cianflone K, Roncari DAK, Maslowska M, Baldo A, Forden J, Sniderman AD. The adipsin-acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry 1994; 33: 9489-95.
3. Germinario R, Sniderman AD, Manuel S, Pratt S, Baldo A, Cianflone K. Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation stimulating protein. Metabolism 1993; 40: 574-80.
4. Yasruel Z, Cianflone K, Sniderman AD, Rosenbloom M, Walsh M, Rodriguez MA. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 1991; 26: 495-9.
5. Tao YH, Cianflone K, Sniderman AD, Colby-Germinario SP, Germinario RJ. Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line. Biochim Biophys Acta - Lipid Metab 1997; 1344: 221-9.
6. Maslowska M, Sniderman AD, Germinario R, Cianflone K. ASP stimulates glucose transport in cultured human adipocytes. Intl J Obesity 1997; 21: 261-6.
7. Baldo A, Sniderman AD, Yazruel Z, Cianflone K. Signal transduction pathway of acylation stimulating protein: involvement of protein kinase C. J Lipid Res 1995; 36: 1415-26.
8. Cianflone K, Maslowska M, Sniderman AD. Impaired response of fibroblasts in patients with hyperapobetalipoproteinemia to acylation stimulating protein. J Clin Invest 1990; 85: 722-30.
9. Kalant D, Zhang ZJ, Cianflone K, Sniderman AD. Specific binding of ASP to human fibroblasts and human adipocytes. Clin Invest Med 1995; 18: B10.
10. Sniderman AD, Shapiro S, Marpole DG, Skinner BF, Kwiterovich PO Jr. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low-density (B) lipoproteins]. Proc Natl Acad Sci USA 1980; 77: 604-8.
11. Sniderman AD, Brown BG, Stewart FF, Cianflone K. From familial combined hyperlipidemia to hyperapo B: Unravelling overproduction of heptic apoB lipoproteins. Curr Opin Lipidol 1992; 3: 137-42.
12. Kwiterovich PO Jr, Coresh J, Bachorik PS. Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged < or = 50 years) and women (< or = 60 years) with coronary artery disease. Am J Cardiol 1993; 71: 631-9.
13. Teng B, Sniderman AD, Soutar AK, Thompson GR. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. J Clin Invest 1986; 77: 663-72.
14. Teng B, Thompson GR, Sniderman AD, Forte TM, Krauss RM, Kwiterovich PO. Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinaemia, normolipidaemia and familial hypercholesterolaemia. Proc Natl Acad Sci USA 1983; 80: 6662-6.
15. Genest J, Sniderman AD, Cianflone K et al. Hyperapobetalipoproteinemia: Plasma lipoprotein responses to oral fat load. Arteriosclerosis 1986; 6: 297-304.
16. Castro Cabezas M, DeBruin TWA, De Valk HW, Shoulders CC, Jansen H, Erkelens DW. Impaired fatty acid metabolism in familial combined hyperlipidemia. Am Soc Clin Invest 1993; 92: 160-8.
17. 2 heterogeneity. NIH Publication 1987: no. 87-2646.
18. Reynisdottir S, Eriksson M, Angelin B, Arner P. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia. J Clin Invest 1995; 95: 2161-9.
19. Sniderman AD, Cianflone K, Frayn K. The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyperapo B. Diabetologia 1997; 40: S152-S154.
20. Kwiterovich PO Jr, Montevalli M, Miller M. Acylation-stimulatory activity in hyperapobetalipoproteinemic fibroblasts: Enhanced cholesterol esterification with another serum basic protein, BPII. Proc Natl Acad Sci USA 1990; 87: 8980-4.
21. Kwiterovich PO Jr, Montevalli M. The effect of three serum basic proteins on the mass of lipids in normal and hyperapo B fibroblasts. Arterioscleros Thrombos 1994; 14: 1-7.
22. Cianflone K, Zhang XJ, Genest J Jr, Sniderman AD. Plasma acylation stimulating protein in coronary artery disease. Arterioscleros, Thrombos Vascular Biol 1997; 17: 1239-44.
23. Saleh J, Summers LKM, Cianflone K, Fielding BA, Sniderman AD, Frayn KN. Coordinated release of acylation stimulating protein and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res 1998; 39: 884-91.
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities or protein utilizing the principal of protein-dye binding. Anal Biochem 1976; 72: 248-54.
25. Motulsky H. The graphpad guide to analyzing radioligand binding data. Internet 1997 www.graphpad.com.
26. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y. Direct activation of calcium-activation, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 1982; 257: 7847-51.
27. Karnieli E, Zarnowski MJ, Hissin PJ, Simpson IA, Solans LB, Cushman SW. Insulin stimulated translocation of glucose transport systems in the isolated rat adipose cell. J Biol Chem 1981; 256: 4772-7.
28. Kirsch D, Obermaier B, Haring HU. Phorbolesters enhance basal D-glucose transport but inhibit insulin stimulation of D-glucose transport and insulin binding in isolated rat adipocytes. Biochem Biophys Res Commun 1985; 128: 824-32.
29. Coresh J, Beaty TH, Kwiterovich PO Jr. Inheritance of plasma apolipoprotein B levels in families of patients undergoing coronary arteriography at an early age. [Review]. Genetic Epidemiol 1993; 10: 159-76.
30. Crass T, Raffetseder U, Martin U, et al. Expression cloning of the human C3a anaphylatoxin receptor (C3a R) from differentiated U-937 cells. Eur J Immunol 1996; 26: 1944-50.
31. Ames RS, Li Y, Sarau HM, et al. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J Biol Chem 1996; 271: 20231-4.
32. Klos A, Bank S, Gietz C, et al. C3a receptor on Dibutyryl-cAMP-differentiated U937 cells and human neutrophils: The human C3a receptor characterized by functional responses and I-C3z binding. Biochemistry 1992; 31: 11274-82.
33. Maslowska M, Scantlebury T, Germinario R, Cianflone K. Acute in vitro production of ASP in differentiated adipocytes. J Lipid Res 1997; 38: 21-31.
34. Peterson J, Bihain BE, Bengtsson-Olivecrona G, Deckelbaum RJ, Carpentier YA, Olivecrona T. Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. Proc Natl Acad Sci USA 1990; 87: 909-13.
35. Saxena U, Wine LD, Goldberg IJ. Release of endothelial lipoprotein lipase by plasma lipoproteins and free fatty acids. J Biol Chem 1989; 264: 4349-55.
36. Bjorntorp P. Fatty acids, hyperinsulinemia, and insulin resistance: which comes first? Curr Opin Lipidol 1994; 5: 166-74.
37. Castro Cabezas M, de Bruin TWA, Jansen H, Kock LAW, Kortlandt W, Erkelens DW. Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arteriosclerosis Thrombosis 1993; 13: 804-14.